Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about TAK
Recent news which mentions TAK
< Previous
1
2
3
4
5
6
Next >
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
March 16, 2023
Tickers
ALG
BBLN
CHH
DINO
Tags
Benzinga
BBLN
HALO
From
Benzinga
Johnson & Johnson's Experimental Dengue Pill Shows Efficacy In Animal Studies
March 15, 2023
Tickers
JNJ
TAK
Tags
General
Health Care
Large Cap
From
Benzinga
Should You Give Up on Novavax?
March 03, 2023
Tickers
MRNA
NVAX
PFE
TAK
Tags
Market News
MRNA
TAK
From
Motley Fool
2 Incredibly Cheap High-Yield Dividend Stocks to Buy Now
February 28, 2023
Tickers
F
TAK
Tags
TAK
Recent Press Releases
F
From
Motley Fool
Takeda Presents Vedolizumab Data For Preventing Graft-Versus-Host Disease In Stem Cell Transplant Patients
February 21, 2023
Tickers
TAK
TKPHF
Tags
Benzinga
TAK
Market News
From
Benzinga
Is This the Telltale Sign to Sell Novavax Stock?
February 14, 2023
Tickers
MRNA
NVAX
PFE
TAK
Tags
MRNA
Market News
PFE
From
Motley Fool
Takeda Reports 13% Fall In Nine Month Operating Profit, Keeps Annual Guidance Unchanged
February 02, 2023
Tickers
TAK
TKPHF
Tags
General
TKPHF
Briefs
From
Benzinga
7 Sorry Dividend Stocks to Sell in February Before It’s Too Late
January 30, 2023
Tickers
BIG
CPB
CWH
D
Tags
NYSE:BIG,NYSE:CPB,NASDAQ:INTC,NYSE:D,NYSE:TAK,NYSE:MO,NYSE:CWH
D
Stocks to Sell
From
InvestorPlace
Finch Therapeutics Halts Work On Its Only Clinical Stage Asset, Cuts 95% Of Workforce
January 24, 2023
Tickers
FNCH
TAK
Tags
Biotech
Briefs
News
From
Benzinga
HUTCHMED Out Licenses Fruquintinib To Takeda Outside China
January 23, 2023
Tickers
HCM
TAK
Tags
Eurasia
Contracts
Biotech
From
Benzinga
Arrowhead Pharmaceuticals Reports Underwhelming Data From Inherited Disease Study
January 09, 2023
Tickers
ARWR
TAK
TKPHF
Tags
General
Health Care
TKPHF
From
Benzinga
A Bullish Sign Appears On Takeda Pharmaceutical's Chart
December 28, 2022
Tickers
TAK
Tags
Benzinga
TAK
Trading Ideas
From
Benzinga
Analyst Bullish On Theseus Pharma's Platform For Gastric Cancer Therapies
December 14, 2022
Tickers
DCPH
PFE
TAK
THRX
Tags
General
News
Briefs
From
Benzinga
Takeda To Add Mid-Stage Autoimmune Disease Candidate For $4B
December 13, 2022
Tickers
TAK
TKPHF
Tags
Movers
Large Cap
Biotech
From
Benzinga
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
December 09, 2022
Tickers
EXEL
IPSEY
RHHBY
TAK
Tags
TAK
Benzinga
Market News
From
Benzinga
Are Tech Layoffs Going to Be a Headache for Alexandria Real Estate Equities?
November 30, 2022
Tickers
AMZN
ARE
BMY
LLY
Tags
AMZN
UBER
ARE
From
Motley Fool
Takeda's Dengue Vaccine Candidate Under FDA Priority Review
November 23, 2022
Tickers
TAK
TKPHF
Tags
TAK
TKPHF
Benzinga
From
Benzinga
Gamma Delta T Cell Therapy Market Could Reach $4 Billion As Biotechs Race To Get Breakthrough Cancer Treatment Approved
November 22, 2022
Tickers
ACET
BMY
IPSC
TAK
Tags
Small Cap
Biotech
TCBP
From
Benzinga
Why Puma Biotechnology's Shares Jumped 20% on Monday
November 21, 2022
Tickers
PBYI
TAK
Tags
Recent Press Releases
PBYI
TAK
From
Motley Fool
Takeda's Approved Blood Cancer Drug Hits Primary Goal In Newly-Diagnosed Patient Settings
November 17, 2022
Tickers
PBYI
TAK
TKPHF
Tags
Large Cap
Biotech
Briefs
From
Benzinga
2 Beaten-Down Dividend Stocks That Haven't Been This Cheap In More Than a Decade
November 16, 2022
Tickers
TAK
VZ
Tags
VZ
Market News
Recent Press Releases
From
Motley Fool
Why Denali Therapeutics' Stock Rose 6.6% on Wednesday
November 02, 2022
Tickers
DNLI
TAK
Tags
Recent Press Releases
DNLI
TAK
From
Motley Fool
Takeda Posts Lower 1H Profit, Lifts FY22 Outlook
October 27, 2022
Tickers
TAK
TKPHF
Tags
Benzinga
TAK
Guidance
From
Benzinga
Earnings Scheduled For October 27, 2022
October 27, 2022
Tickers
OIS
ONTO
OPCH
OPI
Tags
PCG
PEB
PBF
From
Benzinga
7 Dividend Stocks to Sell Pronto Before a Painful Downturn
October 24, 2022
Tickers
CAH
MS
PEP
PG
Tags
PG
CAH
Stocks to Sell
From
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
October 19, 2022
Tickers
AAN
ACMR
AGFY
AKLI
Tags
ACMR
MPA
HIPO
From
Benzinga
3 High-Yielding Dividend Stocks Near Their 52-Week Lows
October 19, 2022
Tickers
DUK
HD
TAK
Tags
Recent Press Releases
DUK
TAK
From
Motley Fool
Takeda Seeks FDA Approval For Hereditary Angioedema Treatment For Younger Kids
October 05, 2022
Tickers
TAK
TKPHF
Tags
Market News
TAK
FDA
From
Benzinga
3 IPO Stocks That You Want to Own
September 25, 2022
Tickers
AMLX
DCGO
HLVX
TAK
Tags
DCGO
TAK
HLVX
From
Motley Fool
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
September 21, 2022
Tickers
PBYI
TAK
Tags
Penny Stocks
PBYI
TAK
From
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.